Ankyrin Repeat Domain 11 (ANKRD11) Peptid
ANKRD11
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
-
- Target Alle ANKRD11 Produkte
- ANKRD11 (Ankyrin Repeat Domain 11 (ANKRD11))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-ANKRD11 antibody (Catalog #: ARP33542_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ANKRD11 (Ankyrin Repeat Domain 11 (ANKRD11))
- Hintergrund
-
ANKRD11 is a member of a novel family of ankyrin repeats containing cofactors (ANCOs) that interact with p160 coactivators to inhibit ligand-dependent transactivation. ANKRD11 encodes a large nuclear protein with five ankyrin repeats, and parts of its sequences have been reported as nasopharyngeal carcinoma susceptibility protein and medulloblastoma antigen. This gene also colocalizes and interacts with histone deacetylases.
Alias Symbols: T13, LZ16, ANCO1, ANCO-1
Protein Interaction Partner: HDAC3,NCOA1,NCOA2,NCOA3,HDAC3,HDAC4,HDAC5,NCOA2,SRC,ANKRD11,HDAC3,NCOA2,NCOA3
Protein Size: 2663 - Molekulargewicht
- 298 kDa
- Gen-ID
- 29123
- NCBI Accession
- NM_013275, NP_037407
- UniProt
- Q9UHR3
-
Sie sind hier:
